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different cell receptors (Hamel et al., 2015), some of them present
in neurons, and can infect and replicate in murine neurons and
astroglia (Bell et al., 1971). Although pregnant women infectedThe recent Zika virus (ZIKV) outbreak has been declared a Public
Health Emergency of International Concern (PHEIC) by the World
Health Organization in February 2016. It started in Brazil in 2015, rapid-
ly spread through South and Central America, and is expected to reach
the continental US in the summer of 2016. The appearance of ZIKV has
been connected with an increase in cases of microcephaly in newborns
of the affected areas and Guillain–Barré Syndrome (GBS) (WHO, 2016).
Since the virus' ﬁrst isolation in Uganda in 1947, the two major out-
breaks happened in Micronesia (2007) and in French Polynesia
(2013). The 2013 outbreak is the only precedent where ZIKV was asso-
ciated with serious complications (GBS) and a causal link between ZIKV
infection and GBS was suggested based on a large study (Cao-Lormeau
et al., 2016). The mechanism of ZIKV-induced GBS is not clear, but one
possibility is cross-reactivity between a viral antigen and the self-
peptide myelin.
The evidence for ZIKV causing fetal microcephaly has been under
debate due to the small number of studies reported, but as new
reports appear every week the evidence seems clearer, although it
has not been scientiﬁcally proven yet. A recent cohort study of 88
pregnant women in Brazil showed that 29% of infected mothers
delivered babies with fetal abnormalities (Brasil et al., 2016).
Furthermore, from nine current reported cases of ZIKV-positive
pregnant women in the US that traveled to ZIKV endemic areas,
ﬁve pregnancies resulted in fetal abnormalities or death, two in
healthy babies while two women are still pregnant (Meaney-
Delman et al., 2016). ZIKV has also been found both in the amniotic
ﬂuid and in fetal brain after pregnant mothers were infected,
supporting the causal link between ZIKV-infected mothers and
fetal microcephaly (Marrs et al., 2016). There are precedents of
closely related neutrotropic ﬂaviviruses that cause neurological dis-
eases. West Nile Virus (WNV) can cause encephalitis and meningitis,
and chikungunya virus (CHIKV) can cause neonatal encephalopathy
and microcephaly (Gerardin et al., 2014). Additionally, other viruses
causing congenitally acquired infections (TORCH) like rubella virus,y, Icahn School of Medicine at
. This is an open access article undercytomegalovirus, herpes simplex virus, varicella zoster virus or HIV
with ZIKV do not show neurological disease, hormonal-induced
changes in immune responses, infections in ZIKV-naïve women or
speciﬁc genetic factors might facilitate increased replication of the
virus in the mother, cross-placental barrier accessibility and
ultimately ZIKV presence in the fetus during early stages of brain
development. Nevertheless, the neuropathogenic effect of ZIKV is
unknown. Similarly to GBS, the induction of mimicry, where
antibodies produced against a viral protein by the mother will recog-
nize a self-protein in the fetus (i.e. during brain development), is
possible, or the presence of ZIKV in the brain could also cause tissue
damage.
ZIKV is a mosquito-borne virus of the family Flaviviridae, genus
Flavivirus. The natural vector for ZIKV transmission is Aedes sp. mosqui-
toes, mainly A. aegypti and A. albopictus species, which also transmit
other ﬂaviviruses as dengue virus (DENV) and CHIKV. This mosquito is
endemic in tropical areas, and may have facilitated ZIKV dispersion
during outbreaks. ZIKV has been also reported to be transmitted by
blood transfusion and sporadically by sexual contact, from a sexual
partner infected while traveling to ZIKV areas. Detection of infective
ZIKV in semen has been conﬁrmed, and an increasing number of poten-
tial sexual transmission cases are currently being investigated by the
CDC (Hills et al., 2016). This poses new challenges to control the
epidemic.
ZIKV infection is asymptomatic in 80% of the cases and the
remainder 20% suffer mild symptoms similar to those induced by
DENV: fever, headache, red eyes, rash, fatigue, muscle and joint pain.
In the current outbreak, cross-reactivity with antibodies from DENV
and CHIKV in the affected areas has stalled the use of ELISA to detect
ZIKV antibodies. The only reliable diagnostic technique available is RT-
PCR testing of serum, but is only positive during the viremia, usually
3–7 days, and of urine, where virus can be detected from 4 up to
30 days after the onset of infection. Tests for semen and saliva are still
under development. Amniotic ﬂuid sampling for PCR has been recom-
mended for pregnant women, especially when the blood test results
are negative. Ultrasound testing can conﬁrm fetal microcephaly, and
additional testing may be performed on fetal tissue, like RT-PCR on
tissue and electron microscopy to detect virus particles, and direct
immunoﬂuorescence suggestive of viral infection within neurons.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Many questions need to be addressed, such as: How does ZIKV
inducemicrocephaly andGBS?What is the real frequency of developing
those complications after ZIKV infection?What would be the risk phase
of pregnancy for ZIKV transfer to the fetus? Can asymptomatic mothers
transmit the virus to the fetus? Are all the ﬂuids positive for ZIKV
contagious? What is the risk of sexual transmission of ZIKV? Is there a
reservoir organ that can shed ZIKV for long periods?
To answer those questions and to effectively track the ZIKV
epidemic, the main effort should be to develop optimal diagnostic tech-
niques. This will allow tracking all the real ZIKV infection cases for epi-
demiological studies and correlation analyses with microcephaly/GBS.
It will facilitate surveillance and cohort studies, to determine the real
percentages of vertically transmitted ZIKV and of fetal death, miscar-
riage, microcephaly or other fetal malformations. A registry has been
created in the US to track and follow up children of mothers infected
during pregnancy, which will provide important information regarding
the long-term effects of ZIKV infection during pregnancy (Oduyebo
et al., 2016).
There is no treatment or vaccine for ZIKV infection, only preventive
and supportive care. More research on therapeutic approaches to
suppress ZIKV spread is needed. Some strategies used for closely related
ﬂaviviruses could be applied to ZIKV, like drugs targeting host factors or
viral proteins required for viral infection. The development of successful
vaccines, similarly to the one for Yellow Fever virus (YFV) and other
ﬂaviviruses, is also a priority and is currently under way in several
laboratories, although this may be a long process.
Animal models like guinea pigs, successfully used for the study of
other congenital and perinatal infections as cytomegalovirus (CMV),
or mice previously tested for ZIKV infection, will be crucial to study
ZIKV infection, neurotropism, and host responses. They will also
facilitate the study of potential vertical transmission of ZIKV and the
conﬁrmation of ZIKVas the causative agent of theneurological disorders
in the fetus as well as conﬁrmation of sexual transmission by Koch's
postulates.
In conclusion, the current ZIKV outbreak has been followed in real
time and highlights the need for coordinated responses to understandhow viruses interact with the host and what factors determine severity
of symptoms. The rapid declaration of PHEIC by theWHOhas initiated a
global response from the scientiﬁc community to hamper the spread of
the virus and to gain knowledge on its pathogenic potential.References
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